Joanna is a Senior Analyst and MedTech Industry Lead. She currently leads engagement with the MedTech industry and has developed expertise in MedTech (medical devices, diagnostics and interventional procedures). Joanna also leads engagement with the NIHR Health Technology Cooperatives (HTCs), and has recently become a member of the Trauma HTC External Advisory Group (HEAG), based at the University Hospitals Birmingham NHS Foundation Trust.
Joanna has recently led a review to identify new and emerging technologies to treat inherited retinal diseases. She worked closely with the charity Fight for Sight (eye research funders) and liaised with the NIHR’s James Lind Alliance. The report was published on the HSC website in July 2014. Joanna is currently working on a draft paper for publication and an abstract, with a view to delivering a presentation at a relevant conference in 2015.
In 2009, Joanna undertook a review to identify new point of care tests for sexually transmitted infections. In 2010, the project was presented at Health Technology Assessment International (HTAi) held in Dublin. An article focusing on Chlamydia testing was published in 2011.
In 2009, Joanna also presented a project on developing evaluation criteria to assess the value of identification sources for horizon scanning centres at HTAi, held in Singapore. The project was published in the International Journal of Technology Assessment in Health Care in 2010.
Joanna has previously worked for the Health Protection Agency’s National Poisons Information Service (NPIS), based at the Sandwell and West Birmingham Hospitals NHS Trust.
Smith J, Cook A, Packer C, Stokes-Lampard H (2011). Testing for Chlamydia trachomatis: is more choice a good thing? Journal of Family Planning and Reproductive Health Care, 37:4-7.
Smith J, Cook A, Packer C (2010). Evaluation criteria to assess the value of identification sources for horizon scanning. International Journal of Technology Assessment in Health Care, 26(3): 348-353.